4//SEC Filing
CAUWENBERGH GEERT 4
Accession 0001209191-18-058091
CIK 0001533040other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 9:24 AM ET
Size
5.7 KB
Accession
0001209191-18-058091
Insider Transaction Report
Form 4
CAUWENBERGH GEERT
DirectorPresident & CEO
Transactions
- Award
Common stock, $0.0001 par value
2018-11-09$0.43/sh+18,698$8,096→ 163,292 total
Holdings
- 450(indirect: By Spouse)
Common stock, $0.0001 par value
Footnotes (1)
- [F1]As reported on a Current Report on Form 8-K filed on September 4, 2018, the reporting person has elected to receive a portion of his compensation in stock in lieu of cash. Accordingly, on November 9, 2018, the reporting person received a total of 18,698 shares of common stock from the Company in lieu of $8,096.16 of cash compensation, which includes base salary, that was payable on such date.
Documents
Issuer
RXi Pharmaceuticals Corp
CIK 0001533040
Entity typeother
Related Parties
1- filerCIK 0001285648
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 9:24 AM ET
- Size
- 5.7 KB